Published in Health and Medicine Week, June 22nd, 2006
The company obtained approval for this PMA supplement in 56 days. The company plans to introduce the Visiflex Delivery System in the U.S. market through a controlled launch program to further develop targeted physician feedback and to build inventory, with full commercialization anticipated in the fall of this year.
The Visiflex Delivery System is designed to provide improved catheter...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.